MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Roxy Jacenko has revealed how she gained 18kg after moving to Singapore in 2023 with her husband Oliver Curtis and their two ...
The funds will support the completion of a crucial Phase II clinical study for their GaRP medication, targeting irritable bowel syndrome, and advance an anti-obesity project. This financial move ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...
Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for ...
Anatara Lifesciences Ltd (AU:ANR) has released an update. Anatara Lifesciences is advancing its Phase II trial for GaRP in treating Irritable ...
5don MSN
Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.
More of our providers are using the Allurion Balloon in combination with GLP-1s. 33% of our patients now have previously tried an anti-obesity medication. That’s up from 25% last year. And what we’re ...
The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback